Mönckeberg sclerosis in patients with thyroid papillary carcinoma

V. Venetsanaki, Eleana Zisimopoulou, Chrysanthi Zouli, M. Boudina, Konstantinos Gkiouras, P. Xirou, Aimilia Fotiadou, M. Stamati, E. Argyropoulou, Alexandra Chrisoulidou
{"title":"Mönckeberg sclerosis in patients with thyroid papillary carcinoma","authors":"V. Venetsanaki, Eleana Zisimopoulou, Chrysanthi Zouli, M. Boudina, Konstantinos Gkiouras, P. Xirou, Aimilia Fotiadou, M. Stamati, E. Argyropoulou, Alexandra Chrisoulidou","doi":"10.1530/eo-23-0047","DOIUrl":null,"url":null,"abstract":"Background: Mönckeberg sclerosis is a form of calcification of the tunica media of small and medium size arteries. It occurs more often in the peripheral arteries of the lower limbs and it has been associated with diabetes and renal disease. Although there are a few reports of Mönckeberg sclerosis in thyroid vessels, there are no data regarding its significance in thyroid disease.\n\nObjective: To investigate the possible prognostic value of Mönckeberg sclerosis in thyroid vessels of patients with diagnosed thyroid cancer.\n\nMethods: We retrospectively studied patients with papillary thyroid cancer treated at the Theagenio Hospital of Thessaloniki from 2005 to 2021. The patients were divided in two groups based on the presence, or not, of histopathological findings of Mönckeberg sclerosis in the thyroid vessels-along with papillary thyroid cancer. Patient characteristics, histopathological details, personal history of thyroid disease and metabolic parameters were compared between the two groups.\n\nResults: Thirty-three patients with papillary thyroid carcinoma and Mönckeberg sclerosis were identified and matched to thirty-three controls with papillary thyroid cancer, without evidence of Mönckeberg sclerosis. The metabolic profile of patients with Mönckeberg sclerosis was not significantly different from those who did not have Mönckeberg sclerosis. Moreover, the comparison between the two groups did not reveal any remarkable differences in terms of the aggressiveness of the disease.\n\nConclusions: The presence of Mönckeberg sclerosis does not seem to impact on histological characteristics of patients with papillary thyroid cancer.","PeriodicalId":508879,"journal":{"name":"Endocrine Oncology","volume":"32 5","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrine Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1530/eo-23-0047","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Mönckeberg sclerosis is a form of calcification of the tunica media of small and medium size arteries. It occurs more often in the peripheral arteries of the lower limbs and it has been associated with diabetes and renal disease. Although there are a few reports of Mönckeberg sclerosis in thyroid vessels, there are no data regarding its significance in thyroid disease. Objective: To investigate the possible prognostic value of Mönckeberg sclerosis in thyroid vessels of patients with diagnosed thyroid cancer. Methods: We retrospectively studied patients with papillary thyroid cancer treated at the Theagenio Hospital of Thessaloniki from 2005 to 2021. The patients were divided in two groups based on the presence, or not, of histopathological findings of Mönckeberg sclerosis in the thyroid vessels-along with papillary thyroid cancer. Patient characteristics, histopathological details, personal history of thyroid disease and metabolic parameters were compared between the two groups. Results: Thirty-three patients with papillary thyroid carcinoma and Mönckeberg sclerosis were identified and matched to thirty-three controls with papillary thyroid cancer, without evidence of Mönckeberg sclerosis. The metabolic profile of patients with Mönckeberg sclerosis was not significantly different from those who did not have Mönckeberg sclerosis. Moreover, the comparison between the two groups did not reveal any remarkable differences in terms of the aggressiveness of the disease. Conclusions: The presence of Mönckeberg sclerosis does not seem to impact on histological characteristics of patients with papillary thyroid cancer.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
甲状腺乳头状癌患者的门克伯格硬化症
背景:门克伯格硬化症是中小动脉中膜钙化的一种形式。它多发生在下肢外周动脉,与糖尿病和肾病有关。虽然有一些关于甲状腺血管门克伯格硬化症的报道,但目前还没有关于其在甲状腺疾病中重要性的数据:调查已确诊甲状腺癌患者甲状腺血管中的门克伯格硬化可能具有的预后价值:我们对 2005 年至 2021 年在塞萨洛尼基 Theagenio 医院接受治疗的甲状腺乳头状癌患者进行了回顾性研究。根据甲状腺血管组织病理学发现的门克贝格硬化与甲状腺乳头状癌是否同时存在,将患者分为两组。对两组患者的特征、组织病理学细节、个人甲状腺疾病史和代谢参数进行了比较:结果:研究人员确定了33名甲状腺乳头状癌和门克贝格硬化症患者,并与33名未发现门克贝格硬化症的甲状腺乳头状癌对照组患者进行了配对。患有门克贝格氏硬化症的患者与未患有门克贝格氏硬化症的患者在代谢方面没有明显差异。此外,两组患者在疾病的侵袭性方面也没有明显差异:结论:门克伯格硬化症的存在似乎不会影响甲状腺乳头状癌患者的组织学特征。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
How to design a theranostic trial? SDHA secondary findings in germline testing: counseling and surveillance considerations Mönckeberg sclerosis in patients with thyroid papillary carcinoma MDM2 regulates the stability of AR, AR-V7, and TM4SF3 proteins in prostate cancer The GLP-1 receptor is expressed in vivo by human metastatic prostate cancer
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1